| Nome |
# |
|
Patologie da sovraccarico di ferro:recenti acquisizioni, file e3ad891a-3ec4-da0e-e053-3705fe0a2b96
|
1.291
|
|
Sorafenib: from literature to clinical practice, file e3ad8916-a30d-da0e-e053-3705fe0a2b96
|
714
|
|
Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases., file e3ad8916-e64f-da0e-e053-3705fe0a2b96
|
714
|
|
Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease, file e3ad8916-d379-da0e-e053-3705fe0a2b96
|
558
|
|
Liver stiffness quantification in patients with non-alcoholic steatohepatitis: comparison of shear wave elastography and transient elastography with liver biopsy correlation, file 077f1828-dc7a-4ec0-a011-2c2489011b3b
|
508
|
|
HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years, file e3ad8916-71ba-da0e-e053-3705fe0a2b96
|
416
|
|
Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C, file e3ad8916-ddea-da0e-e053-3705fe0a2b96
|
416
|
|
Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal
varices in patients with compensated hepatitis C virus cirrhosis, file e3ad8916-5aff-da0e-e053-3705fe0a2b96
|
404
|
|
Changing aetiological factors of hepatocellular carcinoma and their potential impact on the effectiveness of surveillance, file e3ad8916-6253-da0e-e053-3705fe0a2b96
|
394
|
|
Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B, file e3ad8916-5312-da0e-e053-3705fe0a2b96
|
387
|
|
The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease., file e3ad8916-cfd9-da0e-e053-3705fe0a2b96
|
370
|
|
Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response, file e3ad891b-ba87-da0e-e053-3705fe0a2b96
|
370
|
|
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection., file e3ad8916-ddec-da0e-e053-3705fe0a2b96
|
352
|
|
Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study, file e3ad891a-6eba-da0e-e053-3705fe0a2b96
|
327
|
|
The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases, file e3ad8916-71bf-da0e-e053-3705fe0a2b96
|
310
|
|
An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C, file e3ad8916-efbf-da0e-e053-3705fe0a2b96
|
305
|
|
TM6SF2 rs58542926 is not associated with steatosis and fibrosis in largecohort of patients with genotype 1 chronic hepatitis C, file e3ad891b-033f-da0e-e053-3705fe0a2b96
|
292
|
|
Treatment of chronic
hepatitis B: update of the recommendations from the 2007 Italian Workshop, file e3ad8916-56eb-da0e-e053-3705fe0a2b96
|
288
|
|
Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease, file e3ad8916-ed8e-da0e-e053-3705fe0a2b96
|
287
|
|
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis, file e3ad891c-add2-da0e-e053-3705fe0a2b96
|
287
|
|
Prophylaxis and treatment of hepatitis B in immunocompromised patients., file e3ad891d-c9ea-da0e-e053-3705fe0a2b96
|
275
|
|
Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b, file e3ad891a-7651-da0e-e053-3705fe0a2b96
|
264
|
|
Phylogenetic Analysis of isolates from new cases of HBV infection in Southern Italy., file e3ad8918-8d04-da0e-e053-3705fe0a2b96
|
260
|
|
Current practice of chronic hepatitis B treatment in Southern Italy., file e3ad8916-68f8-da0e-e053-3705fe0a2b96
|
258
|
|
Histomorphology of healthy oral mucosa in untreated celiac patients: unexpected association with spongiosis., file e3ad891a-d4b9-da0e-e053-3705fe0a2b96
|
254
|
|
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting., file e3ad8917-0ebd-da0e-e053-3705fe0a2b96
|
248
|
|
Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices., file e3ad8916-596a-da0e-e053-3705fe0a2b96
|
244
|
|
Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C., file e3ad8919-b138-da0e-e053-3705fe0a2b96
|
237
|
|
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program, file e3ad891a-1180-da0e-e053-3705fe0a2b96
|
231
|
|
Liver stiffness measurement by transient elastography predicts early recovery from acute hepatitis, file e3ad8916-5d29-da0e-e053-3705fe0a2b96
|
225
|
|
Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin, file e3ad8916-a454-da0e-e053-3705fe0a2b96
|
225
|
|
HCV-1b intra-subtype variability: Impact on genetic barrier to protease inhibitors, file e3ad8916-a461-da0e-e053-3705fe0a2b96
|
220
|
|
IL28B polymorphisms influence stage of fibrosis and
spontaneous or interferon-induced viral clearance in thalassemia patients with
hepatitis C virus infection., file e3ad8916-5b36-da0e-e053-3705fe0a2b96
|
215
|
|
A patient with acute hepatitis C and possible IFN toxicity [2], file e3ad891a-819e-da0e-e053-3705fe0a2b96
|
209
|
|
Chronic hepatitis C in children is a mild and curable liver disease, file e3ad8916-6c0c-da0e-e053-3705fe0a2b96
|
206
|
|
The presence of White Matter Lesions is not associated with Non-alcoholic Fatty Liver Disease but with its histological severity, file e3ad891c-f2e5-da0e-e053-3705fe0a2b96
|
203
|
|
Current and future challenges in HCV: insights from an Italian experts panel, file e3ad891b-eece-da0e-e053-3705fe0a2b96
|
197
|
|
PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease, file e3ad8916-a2c9-da0e-e053-3705fe0a2b96
|
194
|
|
Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study., file e3ad891c-d676-da0e-e053-3705fe0a2b96
|
194
|
|
NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients, file e3ad891f-c3eb-da0e-e053-3705fe0a2b96
|
190
|
|
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication, file e3ad891c-8ce3-da0e-e053-3705fe0a2b96
|
179
|
|
Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease, file e3ad8918-87d9-da0e-e053-3705fe0a2b96
|
178
|
|
Comparison of Histochemical Stainings in Evaluation of Liver Fibrosis and Correlation with Transient Elastography in Chronic Hepatitis, file e3ad8918-8032-da0e-e053-3705fe0a2b96
|
177
|
|
Quantification of fibrosis by collagen proportionate area predicts hepatic decompensation in hepatitis C cirrhosis, file e3ad891c-d3b2-da0e-e053-3705fe0a2b96
|
176
|
|
Survival of Patients with Hepatocellular Carcinoma (HCC)
Treated by Percutaneous Radio-Frequency Ablation
(RFA) Is Affected by Complete Radiological Response, file e3ad8916-92d5-da0e-e053-3705fe0a2b96
|
163
|
|
Adefovir for lamivudine resistant HBV: More than meets the eye., file e3ad891d-d3a1-da0e-e053-3705fe0a2b96
|
162
|
|
The presence of white matter lesions is associated with the fibrosis severity of nonalcoholic fatty liver disease, file e3ad8919-5179-da0e-e053-3705fe0a2b96
|
154
|
|
Hyperferritinemia is a risk factor
for steatosis in chronic liver disease., file e3ad891a-6d82-da0e-e053-3705fe0a2b96
|
138
|
|
Oral pathology in untreated coeliac disease, file e3ad891b-0359-da0e-e053-3705fe0a2b96
|
137
|
|
Breaking bad news: How to cope, file e3ad891d-9988-da0e-e053-3705fe0a2b96
|
129
|
|
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C., file e3ad8919-a568-da0e-e053-3705fe0a2b96
|
128
|
|
Fibrosis Evaluation by Transient Elastography in Patients With Long-Term Sustained HCV Clearance, file e3ad8916-5e58-da0e-e053-3705fe0a2b96
|
126
|
|
Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population., file e3ad891c-c0d4-da0e-e053-3705fe0a2b96
|
119
|
|
Liver disease in chelated transfusion-dependent thalassemics: the role of iron and chronic hepatitis C, file e3ad8915-91de-da0e-e053-3705fe0a2b96
|
103
|
|
Perception of the role of food and dietary modifications in patients with inflammatory bowel disease: Impact on lifestyle, file e3ad8928-ba25-da0e-e053-3705fe0a2b96
|
101
|
|
The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease, file e3ad8918-94a3-da0e-e053-3705fe0a2b96
|
88
|
|
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease, file e3ad8920-83a3-da0e-e053-3705fe0a2b96
|
68
|
|
The HCV Sicily Network: a web-based model for the management of HCV chronic liver diseases, file e3ad891b-a77b-da0e-e053-3705fe0a2b96
|
63
|
|
Update of the statements on biology and clinical impact of occult hepatitis B virus infection, file e3ad8921-8e44-da0e-e053-3705fe0a2b96
|
57
|
|
Oral Mucosa of celiac disease patients produces anti-endomysial and anti-transglutaminase antibodes. Diagnostic usefulness of an in vitro culture system, file e3ad891a-edc0-da0e-e053-3705fe0a2b96
|
56
|
|
Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies, file e3ad8926-9dfa-da0e-e053-3705fe0a2b96
|
49
|
|
EFFICACY AND SAFETY OF BOCEPREVIR-BASED THERAPY IN
HCVG1 TREATMENT-EXPERIENCED PATIENTS WITH ADVANCED
FIBROSIS/CIRRHOSIS: THE ITALIAN AND SPANISH NPP EARLY
ACCESS PROGRAM, file e3ad8917-0811-da0e-e053-3705fe0a2b96
|
47
|
|
Liver stiffness quantification in patients with non-alcoholic steatohepatitis: comparison of shear wave elastography and transient elastography with liver biopsy correlation, file e3ad891e-c6de-da0e-e053-3705fe0a2b96
|
46
|
|
First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials, file e3ad8927-f1d5-da0e-e053-3705fe0a2b96
|
38
|
|
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy, file e3ad8916-624e-da0e-e053-3705fe0a2b96
|
27
|
|
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease, file e3ad8928-65b7-da0e-e053-3705fe0a2b96
|
27
|
|
Interplay between non-alcoholic fatty liver disease and cardiovascular risk in an asymptomatic general population, file e3ad8926-ebce-da0e-e053-3705fe0a2b96
|
19
|
|
Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort, file e3ad8926-b3ad-da0e-e053-3705fe0a2b96
|
18
|
|
Role of LI-RADS Indeterminate Observations in the Risk of Hepatocellular Carcinoma after HCV Eradication with Direct-Acting Antivirals, file c784078a-7428-4ca7-be17-667c00cf3385
|
11
|
|
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease, file e3ad8926-7f4c-da0e-e053-3705fe0a2b96
|
10
|
|
PNPLA3 rs738409 C>G Variant Predicts Fibrosis Progression by Noninvasive Tools in Nonalcoholic Fatty Liver Disease, file e3ad8926-ff7e-da0e-e053-3705fe0a2b96
|
10
|
|
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease, file 13eb37ee-72fe-4bfe-8fd8-f24dee5a8a14
|
9
|
|
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites, file e3ad8927-519f-da0e-e053-3705fe0a2b96
|
9
|
|
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach, file e3ad8927-6cb5-da0e-e053-3705fe0a2b96
|
9
|
|
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination, file 0bbb3bfd-0a6f-4e1c-8dba-493450fa05d2
|
8
|
|
RESIST-HCV Criteria to Monitor Progression of Low-Risk Esophageal Varices in Patients With Compensated Cirrhosis After HCV Eradication: The SIMPLE Study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices, file 86d1e742-6aec-43f8-b349-32d4e87bfae6
|
8
|
|
Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease, file e3ad891c-70e1-da0e-e053-3705fe0a2b96
|
8
|
|
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial., file e3ad891e-b6e1-da0e-e053-3705fe0a2b96
|
8
|
|
Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort, file e3ad891e-faad-da0e-e053-3705fe0a2b96
|
8
|
|
HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals, file e3ad8923-d6a4-da0e-e053-3705fe0a2b96
|
8
|
|
Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with or without glucose abnormalities: Results of the EGG18 study, file e3ad8927-3c73-da0e-e053-3705fe0a2b96
|
8
|
|
Direct-acting antiviral agents and risk of Hepatocellular carcinoma: Critical appraisal of the evidence, file e3ad8927-fe4a-da0e-e053-3705fe0a2b96
|
8
|
|
A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver disease, file e3ad8928-6259-da0e-e053-3705fe0a2b96
|
8
|
|
Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic hepatitis C aged 75 years or older: A multicentre study, file d0376914-02e8-4f1e-a898-cd51f40e8b9f
|
7
|
|
Protective benefit of minimally invasive liver surgery for hepatocellular carcinoma prior to transplant, file d5b91803-8c82-40a1-b054-545343ca4c6d
|
7
|
|
Impact of virus eradication in patients with compensated hepatitis C virus-related cirrhosis: competing risks and multistate model, file e3ad8919-70a4-da0e-e053-3705fe0a2b96
|
7
|
|
Adult to Adult Living Donor Liver Transplantation in Recipients with Low MELD: A Strategy Intended to Overcome Donor Shortage, file e3ad8927-13f5-da0e-e053-3705fe0a2b96
|
7
|
|
Risk of mortality from anemia and iron overload in nontransfusion-dependent β-thalassemia, file e3ad8928-8fb7-da0e-e053-3705fe0a2b96
|
7
|
|
Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development, file f2680e2e-bfb9-42b4-a4cf-e6b5d695702e
|
7
|
|
AGILE 3+ Score for the Diagnosis of Advanced Fibrosis and for Predicting Liver-related Events in NAFLD, file 252d801d-6541-408b-8b1f-f1f5e313157d
|
6
|
|
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients, file e3ad8921-8e4f-da0e-e053-3705fe0a2b96
|
6
|
|
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis, file e3ad8923-d994-da0e-e053-3705fe0a2b96
|
6
|
|
Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort study, file e3ad8926-c2de-da0e-e053-3705fe0a2b96
|
6
|
|
Sicily Network for Liver Cancer: A Multidisciplinary Network Model for the Management of Primary Liver Tumors, file e3ad8927-13f6-da0e-e053-3705fe0a2b96
|
6
|
|
Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders, file 437459a7-1c45-42bf-bdfd-2a55e4678e6b
|
5
|
|
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease, file a8522ab2-751b-4c19-acff-469c3d6ac74f
|
5
|
|
High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis, file e3ad8916-5a4f-da0e-e053-3705fe0a2b96
|
5
|
|
Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C, file e3ad8916-6246-da0e-e053-3705fe0a2b96
|
5
|
|
Targeted Therapies in Hepatocellular Carcinoma, file e3ad8919-e872-da0e-e053-3705fe0a2b96
|
5
|
|
Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values, file e3ad891b-8734-da0e-e053-3705fe0a2b96
|
5
|
| Totale |
16.544 |